Latest Competition News

Page 17 of 558
PeopleIN Limited reversed its earnings decline in FY26, driven by a 74.8% surge in its Engineering, Trades and Labour division amid Queensland’s booming infrastructure projects. The company’s sharper portfolio focus and strengthened balance sheet set the stage for further growth.
Victor Sage
Victor Sage
31 Aug 2026
AVADA Group lifted revenue by nearly 15% in FY26, driven by Queensland and New South Wales expansion, while managing a $15 million impairment in Victoria that kept the statutory loss steady.
Victor Sage
Victor Sage
31 Aug 2026
Singular Health Group lifted revenues over fivefold to $1.43 million in FY26, driven by US commercial rollouts of its 3DICOM platform, but posted a $6.34 million loss. The company strengthened its US foothold with FDA clearance and a controlling stake in an associate.
Victor Sage
Victor Sage
31 Aug 2026
Joyce Corporation Ltd (ASX: JYC) posted a record FY26 profit of $10.8 million, up 32% on normalised NPAT, underpinned by strong growth in its KWB kitchen and wardrobe business and improved Bedshed franchise performance. The company declared a fully franked final dividend of 17 cents, lifting the full-year payout to 30 cents per share.
Victor Sage
Victor Sage
31 Aug 2026
Michael Hill International delivered a landmark FY26 with record revenue of AU$655.7 million, a 57% jump in comparable EBIT, and reinstated dividends after a strategic turnaround.
Logan Eniac
Logan Eniac
31 Aug 2026
PYC Therapeutics strengthened its financial footing with a $600 million capital raise and made notable clinical progress across four RNA therapeutic programs targeting genetic diseases.
Ada Torres
Ada Torres
28 Aug 2026
Waterco Limited delivered a robust turnaround in FY26 with net profit after tax soaring 61.6% to $15.5 million on modest revenue growth. The company expanded its Swimart franchise, advanced manufacturing insourcing, and boosted dividends to 20 cents per share fully franked.
Victor Sage
Victor Sage
28 Aug 2026
Alterity Therapeutics posted a 285% jump in revenue to A$1.72 million but also a 93% rise in net loss to A$23.4 million for FY2026. The company secured FDA alignment on a single pivotal Phase 3 trial for ATH434 in Multiple System Atrophy, setting the stage for trial start by year-end.
Ada Torres
Ada Torres
28 Aug 2026
Boresight Ltd (ASX: BST) recorded a 46% increase in revenue to $6.38 million for FY26, driven by global sales expansion and strategic investments including an $8 million IPO. Despite this growth, the company posted a $6.66 million net loss, largely due to increased operational expenses and significant share-based payments.
Victor Sage
Victor Sage
28 Aug 2026
PhosCo Ltd has achieved a metallurgical breakthrough at its Gasaat Phosphate Project, producing premium-grade phosphate concentrate with a simplified flotation process, potentially unlocking significant price premiums.
Maxwell Dee
Maxwell Dee
28 Aug 2026
Teaminvest Private Group (ASX: TIP) posted a 19% increase in statutory profit for FY26, driven by strong active portfolio growth and disciplined capital allocation, while preparing to acquire Intelligent Investor in an earnings accretive deal.
Claire Turing
Claire Turing
28 Aug 2026
Foley Wines reported a 258% surge in net profit for FY2026 despite a 5.4% decline in bottled sales revenue, driven by a premiumisation strategy and cost controls.
Victor Sage
Victor Sage
28 Aug 2026

Browse the archive

Full archive